MCD's fourth-quarter U.S. comps sales are hurt by a decline in average checks, though this is partially offset by a slight increase in comparable...

Bio-Rad witnesses growth across the Clinical Diagnostics segment in the fourth quarter, primarily driven by an increased demand for quality control...

TWLO's fourth-quarter 2024 results reflect the benefit of growth in communications revenues and improved cost discipline.

AL's fourth-quarter 2024 earnings were hurt by higher interest expense, driven by the increase in its composite cost of funds and overall outstanding...

Incyte reports mixed fourth-quarter 2024 results as earnings miss estimates while revenues beat the same. Jakafi and Opzelura drive year-over-year...

KNSL's fourth-quarter results reflect continued execution of the company's strategy of disciplined underwriting and technology-enabled low costs.

CYBR's fourth-quarter 2024 results are expected to gain from its shift toward software-as-a-service and subscription-based models.

Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.

DraftKings' fourth-quarter 2024 top line is aided by strong customer engagement, efficient new customer acquisition and the expansion of Sportsbook...

HOOD's fourth-quarter 2024 results surpass estimates on high net interest revenues and a surge in cryptocurrency & options trading. Yet, higher costs...